Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production

GLIA

Volumn 57, Issue 11, 2009, Pages 1216-1226

  So, Eui Young ^a   Kim, Byung S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Astrocytes; CNS inflammation; Cytokine gene activation; TLRs; Viral immunity

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEMYELINATING DISEASE; EMBRYO; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATION; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS INFECTION;

ANIMALS; ASTROCYTES; CARDIOVIRUS INFECTIONS; CHEMOKINE CCL2; CHEMOKINE CCL5; CYTOKINES; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; THEILOVIRUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 69649097190     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20843     Document Type: Article

References (52)

1. Akira S. 2006. TLR signaling. Curr Top Microbiol Immunol 311:1-16.
2. Akira S, Hemmi H. 2003. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85:85-95.
3. Aravalli RN, Hu S, Rowen TN, Palmquist JM, Lokensgard JR. 2005. TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 175:4189-4193.
4. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK. 2002. Novel signal transduction pathway utilized by extracellular HSP70: Role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028-15034.
5. Babcock AA, Wirenfeldt M, Holm T, Nielsen HH, Dissing-Olesen L, Toft-Hansen H, Millward JM, Landmann R, Rivest S, Finsen B, Owens T. 2006. Toll-like receptor 2 signaling in response to brain injury: An innate bridge to neuroinflammation. J Neurosci 26:12826-12837.
6. Barrionuevo P, Cassataro J, Delpino MV, Zwerdling A, Pasquevich KA, Garcia Samartino C, Wallach JC, Fossati CA, Giambartolomei GH. 2008. Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2. Infect Immun 76:250-262.
7. Bettelli E, Korn T, Kuchroo VK. 2007. Th17: The third member of the effector T cell trilogy. Curr Opin Immunol 19:652-657.
8. Boehme KW, Compton T. 2004. Innate sensing of viruses by toll-like receptors. J Virol 78:7867-7873.
9. Bowman CC, Rasley A, Tranguch SL, Marriott I. 2003. Cultured astrocytes express toll-like receptors for bacterial products. Glia 43:281-291.
10. Bsibsi M, Bajramovic JJ, Van Duijvenvoorden E, Persoon C, Ravid R, Van Noort JM, Vogt MH. 2007. Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins. Glia 55:473-482.
11. Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. 2005. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360-374.
12. Carpentier PA, Williams BR, Miller SD. 2007. Distinct roles of protein kinase R, toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia 55:239-252.
13. Dal Canto MC, Kim BS, Miller SD, Melvold RW. 1996. Theiler's murine encephalomyelitis virus-induced demyelination: A model for human multiple sclerosis. Methods 10:453-461.
14. Dal Canto MC, Melvold RW, Kim BS, Miller SD. 1995. Two models of multiple sclerosis: Experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus infection. A pathological and immunological comparison. Microsc Res Tech 32:215-229.
15. Finch CE, Morgan TE. 2007. Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: A position paper. Curr Alzheimer Res 4:185-189.
16. Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103:8459-8464.
17. Henneke P, Morath S, Uematsu S, Weichert S, Pfitzenmaier M, Takeuchi O, Muller A, Poyart C, Akira S, Berner R, Teti G, Geyer A, Hartung T, Trieu-Cuot P, Kasper DL, Golenbock DT. 2005. Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol 174:6449-6455.
18. Honda K, Taniguchi T. 2006. IRFs: Master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6:644-658.
19. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175:4320-4330.
20. Kang MH, So EY, Park H, Kim BS. 2008. Replication of Theiler's virus requires NF-κB-activation: Higher viral replication and spreading in astrocytes from susceptible mice. Glia 56:942-953.
21. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuora Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
22. Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, Choi SY, Park K, Kim JS, Akira S, Na HS, Oh SB, Lee SJ. 2007. A critical role of tolllike receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 282:14975-14983.
23. Kinsner A, Boveri M, Hareng L, Brown GC, Coecke S, Hartung T, Bal-Price A. 2006. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: Selective potentiation of nitric oxide production by muramyl dipeptide. J Neurochem 99:596-607.
24. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW. 2004a. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 101:1315-1320.
25. Kurt-Jones EA, Sandor F, Ortiz Y, Bowen GN, Counter SL, Wang TC, Finberg RW. 2004b. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity. J Endotoxin Res 10:419-424.
26. Kwon D, Fuller AC, Palma JP, Choi IH, Kim BS. 2004. Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP-1 and NF-κB. Glia 45:287-296.
27. Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, Krueger C, Nitsch R, Meisel A, Weber JR. 2007. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol 190:28-33.
28. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ. 2007. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8:1390-1397.
29. Means TK, Golenbock DT, Fenton MJ. 2000. The biology of Toll-like receptors. Cytokine Growth Factor Rev 11:219-232.
30. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. 2002. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 202:13-23.
31. Mines M, Ding Y, Fan GH. 2007. The many roles of chemokine receptors in neurodegenerative disorders: Emerging new therapeutical strategies. Curr Med Chem 14:2456-2470.
32. Mogensen TH, Paludan SR. 2005. Reading the viral signature by Toll-like receptors and other pattern recognition receptors. J Mol Med 83:180-192.
33. Morath S, Geyer A, Spreitzer I, Hermann C, Hartung T. 2002. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect Immun 70:938-944.
34. Nakahira M, Ahn HJ, Park WR, Gao P, Tomura M, Park CS, Hamaoka T, Ohta T, Kurimoto M, Fujiwara H. 2002. Synergy of IL-12 and IL-18 for IFN- gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 168:1146-1153.
35. Olson JK, Miller SD. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916-3924.
36. Palma JP, Kim BS. 2004. The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus. J Neuroimmunol 149:121-129.
37. Palma JP, Kwon D, Clipstone NA, Kim BS. 2003. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-κB activation: Potential role for the initiation of demyelinating disease. J Virol 77:6322-6331.
38. Rebenko-Moll NM, Liu L, Cardona A, Ransohoff RM. 2006. Chemokines, mononuclear cells and the nervous system: Heaven (or hell) is in the details. Curr Opin Immunol 18:683-689.
39. Rubio N, Capa L. 1993. Differential IL-1 synthesis by astrocytes from Theiler's murine encephalomyelitis virus-susceptible and -resistant strains of mice. Cell Immunol 149:237-247.
40. Skias DD, Kim DK, Reder AT, Antel JP, Lancki DW, Fitch FW. 1987. Susceptibility of astrocytes to class I MHC antigen-specific cytotoxicity. J Immunol 138:3254-3258.
41. So EY, Kang MH, Kim BS. 2006. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3. Glia 53:858-867.
42. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'shea JJ, Hunter CA. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8:1363-1371.
43. Syed MM, Phulwani NK, Kielian T. 2007. Tumor necrosis factor-α (TNF-α) regulates Toll-like receptor 2 (TLR2) expression in microglia. J Neurochem 103:1461-1471.
44. Thompson AJ, Locarnini SA. 2007. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol 85:435-445.
45. Triantafilou K, Triantafilou M. 2004. Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4. J Virol 78:11313-11320.
46. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, Takeuchi O, Akira S, Matsuguchi T. 2002. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169:2026-2033.
47. Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R. 2007. Inflammation in Parkinson's diseases and other neurodegenerative diseases: Cause and therapeutic implications. Curr Pharm Des 13:1925-1928.
48. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730-737.
49. Zekki H, Feinstein DL, Rivest S. 2002. The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol 12:308-319.
50. Zhang G, Ghosh S. 2001. Toll-like receptor-mediated NF-κB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 107:13-19.
51. Zhou S, Halle A, Kurt-Jones EA, Cerny AM, Porpiglia E, Rogers M, Golenbock DT, Finberg RW. 2008. Lymphocytic Choriomeningitis Virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses. J Neuroimmunol 194:70-82.
52. Zhu J, Martinez J, Huang X, Yang Y. 2007. Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-β. Blood 109:619-625.